Oxford Nanopore Technologies (ONT.L): Revising estimates, reiterating Buy/High Risk

Research evidence excerpt

Oxford Nanopore Technologies (ONT.L): Revising estimates, reiterating Buy/High Risk

Oxford Nanopore Technologies (ONT.L)

09 July 2026 Citi Research

Citigroup Global Markets Inc. or its affiliates currently has, or had within the past 12 months, the following as investment

banking client(s): Oxford Nanopore Technologies.

Citigroup Global Markets Inc. or its affiliates currently has, or had within the past 12 months, the following as clients, and the

services provided were non-investment-banking, securities-related: Oxford Nanopore Technologies.

services provided were non-investment-banking, non-securities-related: Oxford Nanopore Technologies.

Citigroup Global Markets Inc. or its affiliates acts as a corporate broker to Oxford Nanopore Technologies.

Analysts’ compensation is determined by Citi Research management and Citigroup’s senior management and is based upon

activities and services intended to benefit the investor clients of Citigroup Global Markets Inc. and its affiliates (the “Firm”).

Compensation is not linked to specific transactions or recommendations. Like all Firm employees, analysts receive

compensation that is impacted by overall Firm profitability which includes investment banking, sales and trading, and

principal trading revenues. One factor in equity research analyst compensation is arranging corporate access events between

institutional clients and the management teams of covered companies. Typically, company management is more likely to

participate when the analyst has a positive view of the company.

For financial instruments recommended in the Product in which the Firm is not a market maker, the Firm is a liquidity provider

in such financial instruments (and any underlying instruments) and may act as principal in connection with transactions in